Add to Watchlist
View Current for PMVP
View SuperFeed for PMVP
View Charts for PMVP
Add or remove $PMVP from your watchlists:
Hang tight! We're updating your watchlist data.
This might take a minute...
Pmv Pharmaceuticals Inc
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for … more
Recent Captain Alerts (Last 5)
Alerts are triggered when we detect unusually high conversation volume for $PMVP. Want real-time alerts? Use our Alerts Gadget.
| Alert Date | Alert Algorithm | Price At Alert | Recent Price | Conversation Volume Change | Analysts that triggered alert |
|---|---|---|---|---|---|
|
1654623970
[See Details]
|
Analyst A.I. | $None | $None | +4833% |
|
There is not enough conversation volume about this stock
Conviction History
Bullish vs Bearish Conviction over the last 30 days.
This color denotes Market Hours (US/Eastern)
There is not enough conversation volume about this stock
Thread Explorer
Explore popular threads around $PMVP
There are no threads for this stock
Go to Thread Explorer
Chart Explorer
Explore recent charts, graphs, and media
There are no charts for this stock
Rarely do we see this kind of divergence between value ($SPYV = black line) and growth ($SPYG = red line). Check it out this 5 year chart...
Go to Chart Explorer
Latest News
Get the latest breaking news from the community
There is no recent news for this stock
Loading news, hang tight...
Google Search Trends - Past 12 months
Instantly visualize search trends for this specific symbol
Company Profile
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.Market Cap Type: Small
